Company intelligence / Profile preview

Mymetics Corporation

Lausanne, Vaud, Switzerland

Ownership: Private
Employees: ~14
Development stage: Phase 1

Overview

Mymetics has developed a proprietary virosome-based vaccine platform with several candidates targeting infectious diseases. Clinical results have shown promise, particularly for intranasal influenza and HIV vaccines. The company has secured significant partnerships and non-dilutive funding from organizations like Astellas, Gates Foundation, and PATH-MVI. Its RSV vaccine candidate was outlicensed to Astellas with up to $82 million in potential payments plus royalties. The malaria candidate received support from PATH-MVI; the HIV program received Gates Foundation funding for studies at Texas Biomedical Research Institute.[2]

Therapeutic areas: Infectious Diseases
Modalities: Virosome-based vaccines
Industry: Biotech

Drug pipeline

7 assets

MYM-V101

6 more assets in the full pipeline.

Request access →

Partnerships

Astellas Pharma / RSV Corp – Out-license/collaboration on RSV virosomal vaccines ($82M deal + royalties)[2][4]Gates Foundation – Funding for HIV research/studies at Texas Biomedical Research Institute[2]PATH-MVI – Funding/support for malaria transmission-blocking candidate development [2]

Beyond the preview

Go deeper on Mymetics Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mymetics Corporation.

Explore the full profile